Clinical Trials on First Relapse/Progression in France

Total 486 results

AB Science

Completed

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Relapse Free

Poland, Spain, Bulgaria, France, Germany, Greece, Romania
University Hospital, Strasbourg, France

Unknown

Abortions at Strasbourg University Hospitals

First-trimester Pregnancy

France
Central Hospital, Nancy, France

Terminated

First-time Fathers' Experiences of Childbirth in Lorraine (PRIMIPERE)

First Birth | Fathers

France
University of Paris 5 - Rene Descartes

Unknown

Empathy and Emotional Intelligence Promoted by the Selection Process in 1st Year of Health Studies at the Paris University Medical School (PREMIS)

Health Studies First-year Course Selection

France
Assistance Publique - Hôpitaux de Paris
Roche Pharma AG; Institut du Cerveau et de la Moelle épinière

Recruiting

Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 (INN-MS)

Multiple Sclerosis | Relapse | Primary Progressive Multiple Sclerosis

France
Assistance Publique Hopitaux De Marseille

Completed

A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours. (SFCE METRO 01)

Survival Without Progression

France
University Hospital, Clermont-Ferrand
MedDay Pharmaceuticals SA; OFSEP (Observatoire Français de la Sclérose en Plaques) and other collaborators

Unknown

Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis (IPBio-SeP)

Progressive Multiple Sclerosis

France
University Hospital, Lille

Recruiting

Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease (KETAPAL)

Depression

France
Dr.Laurent Mineur
Merck Serono International SA; BESPIM, CHU Nîmes (data analysis)

Unknown

PREMIUM, Observational Study

First Line WT KRAS mCRC

France
Nantes University Hospital

Terminated

Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)

First Cadaveric Renal Graft

France
Central Hospital, Nancy, France

Completed

Effect of Orthokeratology on Myopia Progression in French Children

Myopia Progression

France
Centre Leon Berard
National Cancer Institute, France; Fondation ARC

Completed

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive (PIK-ORL)

Head and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent Disease

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur; Pathogen Discovery Laboratory

Recruiting

Metatranscriptomic Next Generation Sequencing in First Trimester Trophoblast With Increased Fetal Nuchal Translucency (METAHCN) (METAHCN)

Increased Nuchal Translucency in the First Trimester of Pregnancy

France
Hospices Civils de Lyon

Recruiting

Management of Progressive Disease in Idiopathic Pulmonary Fibrosis (PROGRESSION)

Progressive Idiopathic Pulmonary Fibrosis

France
Nantes University Hospital

Active, not recruiting

A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." (I2D IFM2021_03)

Multiple Myeloma at First Relapse

France
UNICANCER

Completed

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Colorectal Cancer

France
Institut Curie
Celgene Corporation; Intergroupe Francophone du Myelome

Completed

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

Multiple Myeloma | First Relapse

France
Centre Hospitalier Henri Laborit

Recruiting

Effect of the Enriched Environment on the Risk of Relapse (ENVELMIND)

Alcoholic Relapse

France
Hospital St. Joseph, Marseille, France

Recruiting

Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate (DELIVERY)

Prolonged Second Stage of Labor

France
Centre Hospitalier Universitaire de Saint Etienne

Terminated

RElapse After Allograft: Link Between LoCus of Control and QualiTy of Life (REACT)

Allograft | Post-allograft Relapse

France
Hospices Civils de Lyon

Completed

Hematogenous Osteomyelitis in Childhood Can Relapse Dozens of Years in Adulthood

Osteomyelitis | Hematogenous Osteomyelitis Relapse

France
UNICANCER
Sanofi

Active, not recruiting

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse (PEACE2)

Adenocarcinoma of Prostate | Progression of Prostate Cancer

France
European Georges Pompidou Hospital
APHP

Recruiting

Pronostic and Predictive Value of EMT in Localized Lung Cancer (TWISTlung)

Progression | Surgery | NSCLC, Stage I, II, IIIA, IIIB | Epithelial Mesenchymal Transition

France
Assistance Publique - Hôpitaux de Paris

Completed

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia (Schirang)

Schizophrenia Patients With First Rank Symptoms

France
University Hospital, Clermont-Ferrand

Completed

Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.

Patients With Systemic Inflammatory Diseases Receiving for the First Time a Protracted General Corticostroid Therapy

France
Poitiers University Hospital

Recruiting

New Imaging Biomarkers Predictive of MA Progression (MR7T-PRADA)

Alzheimer Disease | Magnetic Resonance Spectroscopy | Ultra High Field 7T | Progression of Disease | MR Biomarkers

France
University Hospital, Grenoble
Société Française d'Anesthésie et de Réanimation

Completed

eFast Diagnosis Performance in Guiding First Aid Resuscitation (eFAST Decision)

eFast Diagnosis Performance in Guiding First Aid Resuscitation and Hemostasis

France
Centre Hospitalier Universitaire de Nīmes

Completed

Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist (CHECKLISTPEP)

First Episode Psychosis

France
Assistance Publique Hopitaux De Marseille

Completed

Feasibility and Acceptability of an Educational Intervention to Improve the Management of Depression in Primary Care.

Patients With Moderate Depression, | First or Second Episode

France
University Hospital, Strasbourg, France

Unknown

TREatment of Uretral STRICTure With Self-catheterization : Tolerance Evaluation (TRESTRICTT)

First or Second Uretral Stenosis | Diagnosed With Uretral Fibroscopy

France
Hospices Civils de Lyon

Completed

Early Palliative Care in Patient With Acute Leukaemia (Pablo Hemato)

Acute Leukaemia in Relapse

France
University Hospital, Montpellier

Recruiting

Vitreous Detachment and Glaucoma Progression (REVEAL)

Glaucoma | Posterior Vitreous Detachment

France
French Innovative Leukemia Organisation
Novartis Pharmaceuticals

Completed

Phase I Study in RAD 001 Patients With Relapse AML

AML

France
Centre Hospitalier Universitaire, Amiens

Completed

Neuropsychological Indicators of SCD Progression (SCD-CI)

Neurocognitive Disorders | Neurodegenerative Diseases | Biomarkers | Cognitive Decline | Subjective Cognitive Decline | Cognitive Assessment

France
University Hospital, Lille
Assistance Publique - Hôpitaux de Paris; Hospices Civils de Lyon; Central Hospital... and other collaborators

Completed

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia (Vandevol)

Acute Lymphoid Leukemia Relapse | Acute Lymphoid Leukemia Relapse After Bone Marrow Transplant

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer (REBIMMUNE)

Lung Cancer

France
Nantes University Hospital

Withdrawn

Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL (RITEPRALL)

CD22+ Relapsed/Refractory B-ALL

France
Centre Hospitalier Universitaire Dijon

Completed

Effectiveness of Transcranial Magnetic Stimulation (TMS) in Smoking Cessation, Combining Withdrawal Stimulation Followed by Maintenance Stimulation to Prevent Relapse. (TabacStim2)

Smoking Cessation

France
ARCAGY/ GINECO GROUP

Terminated

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

First Line Metastatic Breast Cancer

France
Hospices Civils de Lyon

Completed

Ambulatory Prolapse Surgery (PROLAMBU)

Genital Prolapse | Vaginal Floor Prolapse

France
University Hospital, Rouen

Active, not recruiting

Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling (AS-PROGRESSION)

Aortic Valve Stenosis

France
Rennes University Hospital

Recruiting

iMEA : Comparison of Micro-innervation and Muscle Microstructure of the Anal Levator Muscle Between Patients With Urogenital Prolapse and Those Who Are Asymptomatic (iMEA)

Prolapse Genital

France
Centre Hospitalier Universitaire Dijon

Recruiting

Effectiveness of Transcranial Magnetic Stimulation (TMS) in Smoking Cessation, Combining Withdrawal Stimulation Followed by Maintenance Stimulation to Prevent Relapse (TABACSTIM 3)

Smoking Cessation

France
Centre Hospitalier Universitaire de Nīmes

Completed

Posterior IVS Versus Sacrospinous Suspension in Vaginal Vault Prolapse Repair

Vaginal Prolapse

France
NHS Lothian

Completed

Delivery of Audiovisual Information on Early Medical Abortion (EMAVID)

Abortion in First Trimester | Abortion Early

Sweden, United Kingdom, France
Hospices Civils de Lyon

Unknown

Predictive Value of Aortic Stiffness on Recurrence of Atrial Fibrillation After Disconnection of Pulmonary Veins (VARIABLE). (VARIABLE)

First Ablation of Atrial Fibrillation

France
Assistance Publique - Hôpitaux de Paris

Unknown

Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma (KAPKEY)

Kaposi Sarcoma | Progression, Disease

France
GCS Ramsay Santé pour l'Enseignement et la Recherche

Not yet recruiting

Predictive Value of the DD4 Questionnaire on Depressive Relapse After Hospitalization. (PRADESH)

Depressive Episode

France
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University; Université Paris XII

Completed

Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion (ILD-Treg)

Hematologic Neoplasms | Relapse

France
University Hospital, Brest

Not yet recruiting

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode (PEPAMARKER)

First-episode Psychosis

France

Clinical Trials on First Relapse/Progression in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations